2022: Two-year Impact Factor: 4.4
Scopus Journal Metrics
CiteScore (2022): 5.3
SJR(2022): 0.78
Open Access

Health Promot Perspect. 2021;11(4): 382-392. doi: 10.34172/hpp.2021.49
PMID: 35079582        PMCID: PMC8767077


COVID-19 surveillance systems in African countries

Yusuff Adebayo Adebisi 1,2,3 * ORCID, Adrian Rabe 1,4, Don Eliseo Lucero-Prisno III 1,5

Cited by CrossRef: 17

1- Konu Y, Condé S, Gbeasor-Komlanvi F, Sadio A, Tchankoni M, Anani J, Bitty-Anderson A, Mirindi B, Diallo F, MIjiyawa M, Dagnra A, Ekouevi D. SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021. BMC Public Health. 2022;22(1) [Crossref]
2- Owusu I, Adu C, Aboagye R, Mpangah R, Acheampong G, Akyereko E, Bonsu E, Peprah P. Preparing for future outbreaks in Ghana: An overview of current COVID-19, monkeypox, and Marburg disease outbreaks. Health Promot Perspect. 2023;13(3):202 [Crossref]
3- Kuma C, Ngwah E. Covid-19 restrictions and transport sector in Sub-Saharan Africa: insights from Douala City, Cameroon. Proceedings of the Institution of Civil Engineers - Transport. 2024;:1 [Crossref]
4- Mgbere O, Nwabuko O, Olateju O, Adepoju O, Liaw W, Darkoh C, Essien E. Population-based assessment of the burden of COVID-19 infection in African countries: a first-year report card and public health implications. Therapeutic Advances in Infection. 2023;10 [Crossref]
5- Villani L, Gualano M, Ricciardi W. Is Endemicity a Solution for the COVID-19 Pandemic? The Four E's Strategy for the Public Health Leadership. Front Public Health. 2022;10 [Crossref]
6- Kallay R, Mbuyi G, Eggers C, Coulibaly S, Kangoye D, Kubuya J, Soke G, Mossoko M, Kazambu D, Magazani A, Fonjungo P, Luce R, Aruna A. Assessment of the integrated disease surveillance and response system implementation in health zones at risk for viral hemorrhagic fever outbreaks in North Kivu, Democratic Republic of the Congo, following a major Ebola outbreak, 2021. BMC Public Health. 2024;24(1) [Crossref]
7- Abdelatif N, Naidoo I, Dunn S, Mazinu M, Essack Z, Groenewald C, Maharaj P, Msomi N, Reddy T, Roberts B, Zuma K. Heterogeneity in COVID-19 infection among older persons in South Africa: Evidence from national surveillance data. Front Public Health. 2023;11 [Crossref]
8- Adebisi Y, Nwogu I, Alaran A, Badmos A, Bamgboye A, Rufai B, Okonji O, Malik M, Teibo J, Abdalla S, Lucero‐Prisno D, Samai M, Akande‐Sholabi W. Revisiting the issue of access to medicines in Africa: Challenges and recommendations. Public Health Challenges. 2022;1(2) [Crossref]
9- Taofik O, Surajudeen B, Rasheedat I, Sherifat K, Tajudeen I, Abdulazeez I, Rasaq O. Covid-19 infection: Successful global spread, challenges to public health surveillance, and lessons learnt. J Public Health Epidemiol. 2023;15(2):50 [Crossref]
10- Folayan M, Abeldaño Zuñiga R, Virtanen J, El Tantawi M, Abeldaño G, Ishabiyi A, Jafer M, Al-Khanati N, Quadri M, Yousaf M, Ellakany P, Nzimande N, Ara E, Khalid Z, Lawal F, Lusher J, Popoola B, Idigbe I, Khan A, Ayanore M, Gaffar B, Osamika B, Aly N, Ndembi N, Nguyen A. Associations between COVID-19 testing status, non-communicable diseases and HIV status among residents of sub-Saharan Africa during the first wave of the pandemic. BMC Infect Dis. 2022;22(1) [Crossref]
11- Balooch Hasankhani M, Jahani Y, Sharifi H, Jafari-Khounigh A, Khorrami Z. Clustering Countries based on the Trend of COVID-19 Mortality Rates: An Application of Growth Mixture Models. TOPHJ. 2023;16(1) [Crossref]
12- Fawole O, Bello S, Adebowale A, Bamgboye E, Salawu M, Afolabi R, Dairo M, Namale A, Kiwanuka S, Monje F, Namuhani N, Kabwama S, Kizito S, Ndejjo R, Seck I, Diallo I, Makhtar M, Leye M, Ndiaye Y, Fall M, Bassoum O, Mapatano M, Bosonkie M, Egbende L, Lazenby S, Wang W, Liu A, Bartlein R, Sambisa W, Wanyenze R. COVID-19 surveillance in Democratic Republic of Congo, Nigeria, Senegal and Uganda: strengths, weaknesses and key Lessons. BMC Public Health. 2023;23(1) [Crossref]
13- Kabantiyok D, Ninyio N, Shittu I, Meseko C, Emeto T, Adegboye O. Human Respiratory Infections in Nigeria: Influenza and the Emergence of SARS-CoV-2 Pandemic. Vaccines. 2022;10(9):1551 [Crossref]
14- Kyagambiddwa T, Kintu T, Miiro E, Nabalamba F, Asiimwe G, Namutebi A, Abeya F, Lumori B, Ijuka I, Muhindo R, Mutekanga A, Musinguzi R, Natuhwera F, Ngonzi J, Nuwagira E. Thirty-Day Outcomes of Young and Middle-Aged Adults Admitted with Severe COVID-19 in Uganda: A Retrospective Cohort Study. IDR. 2023;Volume 16:2923 [Crossref]
15- Bents S, Viboud C, Grenfell B, Hogan A, Tempia S, von Gottberg A, Moyes J, Walaza S, Hansen C, Cohen C, Baker R. Modeling the impact of COVID‐19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa. Influenza Resp Viruses. 2023;17(12) [Crossref]
16- Idris I, Ayeni G, Adebisi Y. Why many African countries may not achieve the 2022 COVID-19 vaccination coverage target. Trop Med Health. 2022;50(1) [Crossref]
17- Ndiaye N, Thiaw F, Fall A, Kébé O, Diatta K, Dia N, Fall M, Sall A, Faye M, Faye O. Molecular Epidemiology of Enterovirus A71 in Surveillance of Acute Flaccid Paralysis Cases in Senegal, 2013–2020. Vaccines. 2022;10(6):843 [Crossref]
18- Ferreira N, Garibaldi P, Moraes G, Moura J, Klein T, Machado L, Scofoni L, Haddad S, Calado R, Covas D, Fonseca B, Palacios R, Conde M, Borges M. The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil. Public Health in Practice. 2022;4:100301 [Crossref]
19- Hove C, Cilliers L. A structured literature review of the health infodemic on social media in Africa. Jàmbá Journal of Disaster Risk Studies. 2023;15(1) [Crossref]

Indexing and Abstracting

2-year Impact Factor: 4.4


     Linked in Profile

   Academia Profile

Officially associated with The Iranian Health Education & Promotion Association  

Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission